MENU
+Compare
LNTH
Stock ticker: NASDAQ
AS OF
Dec 18, 04:21 PM (EDT)
Price
$92.88
Change
+$0.22 (+0.24%)
Capitalization
4.27B

LNTH Lantheus Holdings Forecast, Technical & Fundamental Analysis

a manufacturer of medical imaging products

LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for LNTH with price predictions
Dec 17, 2024

LNTH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for LNTH turned positive on November 22, 2024. Looking at past instances where LNTH's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where LNTH's RSI Indicator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 22, 2024. You may want to consider a long position or call options on LNTH as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LNTH advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LNTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LNTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.051) is normal, around the industry mean (57.958). P/E Ratio (12.927) is within average values for comparable stocks, (89.727). LNTH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.256) is also within normal values, averaging (19.472).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
LNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LNTH is expected to report earnings to fall 10.00% to $1.53 per share on February 20

Lantheus Holdings LNTH Stock Earnings Reports
Q4'24
Est.
$1.53
Q3'24
Beat
by $0.14
Q2'24
Missed
by $0.03
Q1'24
Beat
by $0.14
Q4'23
Beat
by $0.33
The last earnings report on November 06 showed earnings per share of $1.70, beating the estimate of $1.56. With 394.37K shares outstanding, the current market capitalization sits at 4.27B.
A.I. Advisor
published General Information

General Information

a manufacturer of medical imaging products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
201 Burlington Road
Phone
+1 978 671-8001
Employees
834
Web
https://www.lantheus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SZK12.210.04
+0.33%
ProShares UltraShort Consumer Staples
FDHY48.880.06
+0.12%
Fidelity Enhanced High Yield ETF
YDEC23.22-0.09
-0.38%
FT Vest Intl Eq Mod Bffr ETF Dec
IEDI55.65-0.30
-0.53%
iShares U.S. Consumer Focused ETF
PVAL37.86-0.26
-0.68%
Putnam Focused Large Cap Value ETF

LNTH and Stocks

Correlation & Price change

A.I.dvisor tells us that LNTH and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LNTH and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LNTH
1D Price
Change %
LNTH100%
-0.88%
ACET - LNTH
32%
Poorly correlated
-0.75%
SNDL - LNTH
26%
Poorly correlated
+4.17%
TEVA - LNTH
25%
Poorly correlated
+26.47%
LFCR - LNTH
24%
Poorly correlated
-3.74%
ORGO - LNTH
24%
Poorly correlated
+0.56%
More